Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
23
Number of overlapping holdings
82.1%
% of PBE's 28 holdings also in XBI
16.9%
% of XBI's 136 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 5.1% | 3.5% | 3.5% |
|
GILEAD SCIENCES INC | 5.1% | 3.0% | 3.0% |
|
INCYTE CORP | 4.7% | 2.9% | 2.9% |
|
UNITED THERAPEUTICS CORP | 5.0% | 2.9% | 2.9% |
|
NEUROCRINE BIOSCIENCES INC | 2.8% | 2.8% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to XBI
|
ILLUMINA INC | 5.1% |
|
REGENERON PHARMACEUTICALS | 3.2% |
|
BIO-TECHNE CORPORATION | 2.8% |
|
BIOGEN IDEC INC | 2.7% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 2.7% |
|
ROYALTY PHARMA PLC CLASS A | 2.6% |
|
AXSOME THERAPEUTICS, INC. | 2.6% |
|
AMGEN INC | 2.5% |
|
BIOCRYST PHARMACEUTICALS INC | 2.4% |
|
CATALYST PHARMACEUTICAL PART | 2.4% |
PBE Underweight Relative to XBI
|
ADVENTRX PHARMACEUTICALS INC | -2.8% |
|
INSMED INC | -2.6% |
|
VERTEX PHARMACEUTICALS INC | -2.6% |
|
ALNYLAM PHARMACEUTICALS INC | -2.5% |
|
ABBVIE INC | -2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.2% |
|
VIKING THERAPEUTICS, INC. | -1.9% |
|
CYTOKINETICS INC | -1.6% |
|
MODERNA, INC. | -1.6% |
|
CRISPR THERAPEUTICS AG | -1.5% |